Pure Science

Plan de Classement de la BSI

"Le plan de classement de la BSI est spécifique. Dès l’origine, il a été choisi de ne pas utiliser les classifications préexistantes, telles que la CDU ou la Dewey. La BSI a donc élaboré son propre outil.

"The BSI classification scheme is specific, and from the outset it has been chosen not to use pre-existing classifications such as CDU or Dewey, so BSI has developed its own tool.

Biomimicry Taxonomy

"The Biomimicry Taxonomy is a classification system developed by the Biomimicry Institute to organize biological content on the website AskNature. The taxonomy categorizes the different ways that organisms and natural systems meet functional challenges into groups of related functions.
Use the taxonomy to help you navigate AskNature or, when beginning a design challenge, as a tool to help you 'think functionally' and identify questions you can 'ask' nature."

Online Taxonomic Key Application

"Welcome to Online Taxonomic Keys, a joint project of Fisheries and Oceans Canada and the Royal BC Museum. This project seeks to facilitate the development of, and make readily available, a variety of regional and global identification keys in a format that is concise and easy to use. The information presented is compiled from published and unpublished works from taxonomic specialists worldwide.


"Paikkatieto-ontologian (PTO) toinen versio muodostuu Yleisestä suomalaisesta ontologiasta (YSO) ja sitä täydentävistä noin 1020 paikkatietokäsitteestä. Paikkatietokäsitteet ovat peräisin Geoinformatiikan sanaston 2. laitoksesta, Paikkatietohakemiston hakusanastosta ja Euroopan komission antamista paikkatietoaineistojen ja -palvelujen yhteentoimivuutta koskevista asetuksista 1089/2010 ja 1253/2013. Viimeksi mainitut käsitteet ovat INSPIRE-direktiivin mukaisia paikkatietokohdetyyppejä.


"The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. The database contains 8246 drug entries including 2012 FDA-approved small molecule drugs, 229 FDA-approved biotech (protein/peptide) drugs, 94 nutraceuticals and over 6000 experimental drugs. Additionally, 4344 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries.